Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
01/05/2000 | EP0968182A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
01/05/2000 | EP0968180A1 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase ii |
01/05/2000 | EP0968168A1 Aromatic tetracyclic compounds of the retinoid type, method for preparing and use |
01/05/2000 | EP0968002A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
01/05/2000 | EP0967997A1 Pharmaceutical composition for eliminating membrane-mediated cell resistance |
01/05/2000 | EP0967995A1 Composition comprising immunoglobulin |
01/05/2000 | EP0967990A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS |
01/05/2000 | EP0967987A1 Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents |
01/05/2000 | EP0967986A2 USE OF HUMAN alpha 1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION |
01/05/2000 | EP0967977A1 Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimidazole, and optionally a potentiator |
01/05/2000 | EP0967973A2 Mediation of cytokines by melanin |
01/05/2000 | EP0967878A1 Targeted cytotoxic cells |
01/05/2000 | EP0946173A4 Preparation of 3-fluoro oxindole derivatives |
01/05/2000 | EP0711299B1 AZABICYCLOALKYL DERIVATIVES OF IMIDAZO(1,5-a)INDOL-3-ONE AS 5HT 3 ANTAGONISTS |
01/05/2000 | EP0673234B1 Tissue protective and regenerative compositions |
01/05/2000 | EP0666856B1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
01/05/2000 | EP0593595B1 Derivatives of inositol, preparations containing them and their use |
01/05/2000 | EP0539420B1 substituted thiazolyl and substituted pyridinyl derivatives |
01/05/2000 | EP0427765B1 Alkoxy-4(1h)-pyridone derivatives, processes for preparing them and their use as drugs |
01/05/2000 | DE19915954A1 Cyclooxygenaseinhibitor Cyclooxygenase |
01/05/2000 | DE19829844A1 Verwendung von D-Galaktose zur Verhinderung von Nekrosen Use of D-galactose to prevent necrosis |
01/05/2000 | DE19828113A1 Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV Prodrugs of inhibitors of dipeptidyl peptidase IV |
01/05/2000 | CN1240450A Thienopyrimidine with phosphodiesterase V inhibiting effect |
01/05/2000 | CN1240438A Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them |
01/05/2000 | CN1240357A Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
01/05/2000 | CN1048015C Bicyclic tetrahydro pyrazolopyridines |
01/04/2000 | US6011159 Processes and intermediates for preparing substituted indazole derivatives |
01/04/2000 | US6011138 Gamma-1 anti-human CD23 monoclonal antibodies |
01/04/2000 | US6011068 Carbocyclic-alkyl secondary amines |
01/04/2000 | US6011061 Therapeutic methods and preparations using rubidium ions |
01/04/2000 | US6011055 Administering indomethacin, naproxen, ibuprofen, tenidap and imiquod in a pharmacologically acceptable carrier, excipient or diluent. |
01/04/2000 | US6011051 Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
01/04/2000 | US6011050 Substituted phenethylsulfones and method of reducing TNFα levels |
01/04/2000 | US6011045 Inhibitors of bone resorption; anticancer agents |
01/04/2000 | US6011040 Use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine |
01/04/2000 | US6011035 Libraries of these compounds can also be used to identify antagonists for other targets. compounds containing benzhydril and 6-membered heterocyclic moieties |
01/04/2000 | US6011029 Benzodiazepine compounds |
01/04/2000 | US6011028 Cyclic amidino agents useful as nitric oxide synthase inhibitors |
01/04/2000 | US6011026 P-(aminoalkoxyphenyl)-steroid derivative |
01/04/2000 | US6011025 11-(substituted phenyl)-estra-4,9-diene derivatives |
01/04/2000 | US6011015 Angiotensin II for improving fertilization |
01/04/2000 | US6010906 Antisense modulation of Jun N-terminal kinase kinase-1 expression |
01/04/2000 | US6010905 Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells |
01/04/2000 | US6010878 Interleukin-1 β converting enzyme like apoptotic protease-6 |
01/04/2000 | US6010874 Early onset alzheimer's disease gene and gene products |
01/04/2000 | US6010872 Recombinant production of TGF-β type III receptor (betaglycan) polypeptides |
01/04/2000 | US6010701 Cell proliferator and applications thereof |
01/04/2000 | CA2194103C Polypeptides useful as calcium channel blockers |
01/04/2000 | CA2022848C Process for disinfecting musculoskeletal tissue and tissues prepared thereby |
01/02/2000 | CA2269999A1 Novel compound |
01/01/2000 | CA2276984A1 Cyclooxygenase inhibitor |
12/30/1999 | DE19827907A1 Synergistic composition for treating infant or adult respiratory distress syndrome |
12/29/1999 | WO1999067809A1 Compositions and methods for inhibiting bone resorption |
12/29/1999 | WO1999067417A2 Fitness assay and associated methods |
12/29/1999 | WO1999067408A1 Mumbaistatin, a process for its production and its use as a pharmaceutical |
12/29/1999 | WO1999067407A2 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof |
12/29/1999 | WO1999067377A1 Human arf-related proteins |
12/29/1999 | WO1999067363A1 Ependymal neural stem cells and method for their isolation |
12/29/1999 | WO1999067283A2 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
12/29/1999 | WO1999067279A1 Compounds of unstable dipeptidyl peptidase iv inhibitors |
12/29/1999 | WO1999067278A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
12/29/1999 | WO1999067276A1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds |
12/29/1999 | WO1999067275A1 Unsaturated 14,15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds |
12/29/1999 | WO1999067273A1 Meiosis regulating compounds |
12/29/1999 | WO1999067271A1 Testosterone derivative |
12/29/1999 | WO1999067266A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
12/29/1999 | WO1999067265A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
12/29/1999 | WO1999067254A2 Multi-drug resistant retroviral protease inhibitors and use thereof |
12/29/1999 | WO1999067252A2 Epothilone derivatives and their synthesis and use |
12/29/1999 | WO1999067244A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones |
12/29/1999 | WO1999067237A1 4,5,6 and 7-indole and indoline derivatives, their preparation and use |
12/29/1999 | WO1999067236A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
12/29/1999 | WO1999067229A1 New 2-aminocarbonyl-5(2h)-isoxazolones as ligands of a dfp-binding site for treatment of cns-diseases |
12/29/1999 | WO1999067221A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
12/29/1999 | WO1999067220A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
12/29/1999 | WO1999067215A1 Amidino and guanidino azetidinone tryptase inhibitors |
12/29/1999 | WO1999067210A1 Stable no-delivering compounds |
12/29/1999 | WO1999067201A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
12/29/1999 | WO1999066959A2 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
12/29/1999 | WO1999066952A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
12/29/1999 | WO1999066951A2 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
12/29/1999 | WO1999066950A1 Synthetic somatostatin immunogen for growth promotion in farm animals |
12/29/1999 | WO1999066948A2 Use of a dipeptide for stimulating repair processes |
12/29/1999 | WO1999066947A1 Adjuvant therapy |
12/29/1999 | WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors |
12/29/1999 | WO1999066941A1 Herbal extract composition and method with immune-boosting capability |
12/29/1999 | WO1999066938A1 Composition containing sulfur hexafluoride and oxygen, for increasing or decreasing the body temperature of a patient |
12/29/1999 | WO1999066936A1 Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv |
12/29/1999 | WO1999066934A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
12/29/1999 | WO1999066932A1 New use of a pyridazinone derivative |
12/29/1999 | WO1999066930A1 Compositions and methods for treating elevated blood cholesterol |
12/29/1999 | WO1999066926A1 Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds) |
12/29/1999 | WO1999066925A1 Protease inhibitors |
12/29/1999 | WO1999066923A1 Application for utility patent for improved enriched platelet wound healant |
12/29/1999 | WO1999066918A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
12/29/1999 | WO1999066917A2 Composition comprising ss-hydroxy-ss-methylbutyric acid and at least one amino acid |
12/29/1999 | WO1999066913A2 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein |
12/29/1999 | WO1999066908A1 Matrix-type transdermal patch for steroid hormones |
12/29/1999 | WO1999066875A2 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism |
12/29/1999 | WO1999057320B1 Antisense modulation of cd40 expression |